Molly Henderson

Insider Reports History

Location
Princeton, NJ
Signature
/s/ Molly Henderson
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Molly Henderson:

Company Role Class Num Shares Value Price $ Report Date Ownership
Phathom Pharmaceuticals, Inc. CFO and CBO Common Stoock 102,763 $1,140,669 $11.10 31 May 2024 Direct
Phathom Pharmaceuticals, Inc. CFO and CBO Common Stock 89,868 $409,016 $4.55 07 Apr 2025 Direct
UroGen Pharma Ltd. Chief Financial Officer Ordinary Shares 5,248 $94,516 $18.01 31 Jan 2022 Direct
Phathom Pharmaceuticals, Inc. CFO and CBO Common Stock 1,911 $8,699 $4.55 07 Apr 2025 By 401(k)
Phathom Pharmaceuticals, Inc. CFO and CBO Stock Option (Right to Buy) 50,000 27 Feb 2025 Direct
UroGen Pharma Ltd. Chief Financial Officer Stock Option (right to buy) 30,000 31 Jan 2022 Direct
UroGen Pharma Ltd. Chief Financial Officer Restricted Stock Units 7,500 31 Jan 2022 Direct

Insider Reports Filed by Molly Henderson

Symbol Company Period Transactions Value $ Form Type Role Filing Time
PHAT Phathom Pharmaceuticals, Inc. 07 Apr 2025 1 -$16,740 4 CFO and CBO 08 Apr 2025, 17:01
PHAT Phathom Pharmaceuticals, Inc. 27 Feb 2025 2 $0 4 CFO and CBO 03 Mar 2025, 17:15
PHAT Phathom Pharmaceuticals, Inc. 21 Jan 2025 1 -$43,371 4 CFO and CBO 23 Jan 2025, 16:24
PHAT Phathom Pharmaceuticals, Inc. 19 Dec 2024 1 -$10,328 4 CFO and CBO 20 Dec 2024, 16:20
PHAT Phathom Pharmaceuticals, Inc. 15 Jul 2024 1 -$50,689 4 CFO and CBO 17 Jul 2024, 14:51
PHAT Phathom Pharmaceuticals, Inc. 31 May 2024 1 $0 4 CFO and CBO 31 May 2024, 18:37
PHAT Phathom Pharmaceuticals, Inc. 08 Apr 2024 1 -$38,128 4 CFO and CBO 10 Apr 2024, 16:30
PHAT Phathom Pharmaceuticals, Inc. 18 Jan 2024 2 -$48,900 4 CFO and CBO 22 Jan 2024, 20:22
PHAT Phathom Pharmaceuticals, Inc. 20 Nov 2023 1 -$15,403 4 CFO and CBO 21 Nov 2023, 16:40
PHAT Phathom Pharmaceuticals, Inc. 01 Nov 2023 3 -$110,871 4 CFO and CBO 03 Nov 2023, 16:55
PHAT Phathom Pharmaceuticals, Inc. 14 Jul 2023 1 $0 4/A CFO and CBO 21 Jul 2023, 20:30
PHAT Phathom Pharmaceuticals, Inc. 02 Jun 2023 1 -$22,368 4 CFO and CBO 05 Jun 2023, 18:32
PHAT Phathom Pharmaceuticals, Inc. 22 May 2023 1 -$27,165 4 CFO and CBO 23 May 2023, 12:15
PHAT Phathom Pharmaceuticals, Inc. 06 Apr 2023 1 -$25,002 4 CFO and CBO 07 Apr 2023, 15:18
PHAT Phathom Pharmaceuticals, Inc. 01 Mar 2023 1 -$17,335 4 CFO and CBO 03 Mar 2023, 18:03
PHAT Phathom Pharmaceuticals, Inc. 19 Jan 2023 2 $0 4 CFO and CBO 20 Jan 2023, 18:32
PHAT Phathom Pharmaceuticals, Inc. 21 Nov 2022 1 -$20,726 4 CFO and CBO 23 Nov 2022, 15:10
PHAT Phathom Pharmaceuticals, Inc. 01 Sep 2022 1 $0 4 CFO and CBO 02 Sep 2022, 16:05
PHAT Phathom Pharmaceuticals, Inc. 19 May 2022 1 $0 4 CFO and CBO 20 May 2022, 17:17
PHAT Phathom Pharmaceuticals, Inc. 13 May 2022 1 $0 4 CFO and CBO 16 May 2022, 20:43
PHAT Phathom Pharmaceuticals, Inc. 05 Apr 2022 2 $0 4 CFO and CBO 06 Apr 2022, 20:50
PHAT Phathom Pharmaceuticals, Inc. 05 Apr 2022 0 $0 3 CFO and CBO 06 Apr 2022, 20:46
URGN UroGen Pharma Ltd. 31 Jan 2022 5 -$2,509 4 Chief Financial Officer 02 Feb 2022, 15:34
URGN UroGen Pharma Ltd. 30 Nov 2021 3 -$31,122 4 Chief Financial Officer 02 Dec 2021, 12:15
URGN UroGen Pharma Ltd. 05 Jun 2021 1 $0 4 Chief Financial Officer 08 Jun 2021, 14:33
URGN UroGen Pharma Ltd. 17 May 2021 1 +$39,625 4 Chief Financial Officer 18 May 2021, 11:36